AMARIN CORP PLC -ADR (AMRN:NASDAQ)
$13.8 -0.24 (-1.7094%)
Analysed AMARIN CORP PLC -ADR (AMRN:NASDAQ) News Sources
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
31-08-2026
yahoo.com
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
10-09-2026
yahoo.com
Amarin Q2 Earnings Call Highlights
29-07-2026
marketbeat.com
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
29-07-2026
advfn.com
Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short
29-07-2026
yahoo.com
Amarin Corp PLC (AMRN) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges
29-07-2026
yahoo.com
Amarin (AMRN) Q2 2026 Earnings Call Transcript
08-08-2026
fool.com
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
24-08-2026
yahoo.com
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026
24-08-2026
advfn.com
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
09-09-2026
yahoo.com
What is the current price of AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The current price of AMARIN CORP PLC -ADR (AMRN:NASDAQ) is $13.8.
AMARIN CORP PLC -ADR (AMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMARIN CORP PLC -ADR (AMRN:NASDAQ) since the previous trading day is $-0.24.
AMARIN CORP PLC -ADR (AMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMARIN CORP PLC -ADR (AMRN:NASDAQ) since the previous trading day is -1.7094%.
What is the most recent average sentiment score for AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The most recent average sentiment score for AMARIN CORP PLC -ADR (AMRN:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for AMARIN CORP PLC -ADR (AMRN:NASDAQ)?
The most recent sentiment for AMARIN CORP PLC -ADR (AMRN:NASDAQ) is .
SEC-8K** Filing Available For AMARIN CORP PLC -ADR (AMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.